Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: Results from PETAL consortium.
Journal: Blood advances
Year: August 29, 2024
Hematologist-Oncologist
5
No OPD information available
Cutaneous T-Cell Lymphoma (CTCL)
T-Cell Lymphoma
Mycosis Fungoides
Non-Hodgkin Lymphoma
Peripheral T-Cell Lymphoma
Sezary Syndrome
Anaplastic Large Cell Lymphoma
Angioimmunoblastic T-cell Lymphoma
Hodgkin Lymphoma
Lymphofollicular Hyperplasia
Lymphomatoid Papulosis
Carrie A. Van Der Weyden is a female medical professional who specializes in treating different types of lymphomas, which are types of cancer that affect the lymphatic system in the body. Some of the conditions she helps patients with include Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, Non-Hodgkin Lymphoma, and others.
Carrie A. Van Der Weyden uses her special skills and knowledge to provide the best care for her patients. She is known for her expertise in diagnosing and treating various types of lymphomas, which helps her patients feel confident in her abilities.
Patients trust Carrie A. Van Der Weyden because she communicates with them in a caring and understanding way. She takes the time to listen to their concerns and explains their treatment options in a clear and supportive manner.
Carrie A. Van Der Weyden stays updated with the latest medical knowledge and research to ensure that her patients receive the most effective and advanced treatments available. This dedication to learning helps her provide the best care possible for her patients.
In her work, Carrie A. Van Der Weyden collaborates closely with other medical professionals to ensure that her patients receive comprehensive and coordinated care. Her relationships with colleagues are built on mutual respect and a shared commitment to improving patient outcomes.
Carrie A. Van Der Weyden's work has had a positive impact on many patients' lives by providing them with effective treatments and compassionate care. Her dedication to helping patients navigate their health challenges has made a difference in the lives of those she treats.
One of Carrie A. Van Der Weyden's notable publications is "Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: Results from PETAL consortium," which was published in Blood advances on August 29, 2024.
Carrie A. Van Der Weyden's expertise, compassion, and commitment to advancing medical knowledge make her a trusted and respected healthcare professional in the field of lymphoma treatment.
Journal: Blood advances
Year: August 29, 2024
Carrie A. Van Der Weyden is an amazing Hematologist-Oncologist. She is caring and knowledgeable, making me feel at ease during my appointments.
Dr. Van Der Weyden is a top-notch specialist in Hematology-Oncology. She explained my treatment plan clearly and supported me every step of the way.
I highly recommend Carrie A. Van Der Weyden for anyone seeking a compassionate Hematologist-Oncologist. She truly goes above and beyond for her patients.
Dr. Van Der Weyden is a skilled Hematologist-Oncologist who always takes the time to listen to my concerns and address them with care.
Carrie A. Van Der Weyden is a fantastic Hematologist-Oncologist. Her expertise and kindness make a difficult journey much more manageable.
Dr. Van Der Weyden is a true professional in the field of Hematology-Oncology. Her dedication to her patients is evident in the quality of care she provides.
I am grateful for the exceptional care I received from Carrie A. Van Der Weyden, a skilled Hematologist-Oncologist. She made me feel supported throughout my treatment.
Dr. Van Der Weyden is a compassionate and knowledgeable Hematologist-Oncologist. I felt confident in her expertise and appreciated her personalized approach to my care.
Carrie A. Van Der Weyden is an outstanding Hematologist-Oncologist who truly cares about her patients' well-being. I am grateful for her expertise and support.